TSXV - Delayed Quote CAD
Arch Biopartners Inc. (ARCH.V)
At close: October 18 at 3:59 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Richard Gabriel Muruve | Co-Founder, CEO, President & Director | 150k | -- | 1971 |
| Dr. Daniel Abraham Muruve M.D. | Co-Founder, Chief Science Officer & Member of Scientific Advisory Board | -- | -- | -- |
| Mr. Andrew Bishop CFA | CFO & Director | -- | -- | 1966 |
| Dr. Justin MacDonald Ph.D. | Co-Founder & Principal Scientist | -- | -- | -- |
| Dr. Paul Beck | Co-Founder & Principal Scientist | -- | -- | -- |
| Mr. Aaron Benson | Director of Communications | -- | -- | -- |
Arch Biopartners Inc.
27 Street Clair Avenue East
PO Box 305
Toronto, ON M4T 2M5
Canada
- Sector:?
- Healthcare
- Industry:? Biotechnology
Description
Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug candidate LSALT Peptide, a product in Phase 2 clinical trials to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys. The company also develops AB569 for treating antibiotic-resistant bacterial infections, and for the treatment of wounds; and Borg, a peptide-solid surface interface to reduce corrosion of metals. Arch Biopartners Inc. is based in Toronto, Canada.
Corporate Governance
Arch Biopartners Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 29, 2024 at 8:00 PM UTC
Arch Biopartners Inc. Earnings Date
Recent Events
September 13, 2000 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
BLRX.TA BioLineRx Ltd.
13.00
+2.36%
CYTO.V Cytophage Technologies Ltd.
0.3300
+1.54%
NBTX Nanobiotix S.A.
4.7300
-4.64%
BIOV.CN BioVaxys Technology Corp.
0.0500
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1450
+3.57%
MIR.V MedMira Inc.
0.0800
0.00%
FHTX Foghorn Therapeutics Inc.
7.67
-0.90%
BLTE Belite Bio, Inc
56.95
+1.70%
PULM Pulmatrix, Inc.
2.0204
-0.47%
LYEL Lyell Immunopharma, Inc.
1.1700
-0.85%